VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $165,145 | -18.6% | 15,752 | +196.9% | 0.02% | -18.5% |
| Q1 2022 | $203,000 | +290.4% | 5,305 | +195.9% | 0.03% | +285.7% |
| Q3 2021 | $52,000 | -49.0% | 1,793 | -40.6% | 0.01% | -41.7% |
| Q2 2021 | $102,000 | +56.9% | 3,021 | +49.4% | 0.01% | +9.1% |
| Q1 2021 | $65,000 | -9.7% | 2,022 | 0.0% | 0.01% | -26.7% |
| Q4 2020 | $72,000 | -99.9% | 2,022 | +59.6% | 0.02% | -40.0% |
| Q3 2020 | $50,500,000 | -9.6% | 1,267 | -12.4% | 0.02% | -19.4% |
| Q2 2020 | $55,835,000 | +730.3% | 1,446 | +395.2% | 0.03% | +675.0% |
| Q1 2020 | $6,725,000 | -18.7% | 292 | 0.0% | 0.00% | -20.0% |
| Q4 2019 | $8,267,000 | – | 292 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |